WOMBAT (ANZUP 2201): A Phase 2, Single-arm Study of Bipolar Androgen Therapy in Patients with Nonmetastatic Castration-resistant Prostate Cancer with Prostate-specific Antigen Progression on Darolutamide
Year: 2026
Type: article
Source: European Urology Oncology
Authors: Barak Talmor, Carole A. Harris, Christopher Gianacas, David Pook, Thean Hsiang Tan, Ian D. Davis, Laurence Krieger, Gavin Marx, Arsha Anton, Sharad Sharma, Jeffrey C. Goh, Kay Xu, Ganes Pranavan, Haryana M. Dhillon, Emmanuel S. Antonarakis, Samuel R. Denmeade, Lisa Horvath, Samantha R. Oakes, Ray Allen, Antoinette Fontela, Elizabeth Reich, Megan Crumbaker, Joshua Hurwitz, Anthony M. Joshua
Institutions: St Vincent's Hospital Sydney, The Kinghorn Cancer Centre, UNSW Sydney, The George Institute for Global Health, St George Hospital, Australian and New Zealand Urogenital and Prostate Cancer Trials Group, Royal Adelaide Hospital, Eastern Health, Monash University, GenesisCare, Australian National University, Sydney Adventist Hospital, Grampians Health, Canberra Hospital, The University of Sydney, University of Minnesota, Masonic Cancer Center, Johns Hopkins University, Chris O’Brien Lifehouse
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7130850695